640 - Factors Associated with Discontinuation of Oral Immunotherapy Treatment for Food Allergies in Clinical Practice

Eirene Fithian, Weill Cornell Medicine, New York, NY, United States; Allison Anderson, Latitude Food Allergy Care, Seattle, WA, United States; Samuel Shrank, Latitude Food Allergy Care, Boulder, CO, United States; Zahida Rani Maskatia, Latitude Food Allergy Care, Redwood City, CA, United States; Charlene Thomas, Weill Cornell Medicine, New York, NY, United States; Priya Katari, Weill Cornell Medicine, New York, NY, United States; Perdita Permaul, NY-Presbyterian/Weill Cornell Medicine, New York, NY, United States